4.0 4.1 4.2 Milner, Joshua (2015), Research Update: POTS, EDS, MCAS Genetics , Washington DC: Dysautonomia International Conference & CME Lyons, Jonathan J
Specific Populations Patients with Renal Impairment An approximately 2-fold increase in the plasma AUC of sitagliptin was observed in patients with moderate renal impairment with eGFR of 30 to less than 45 mL/min/1.73 m2, and an approximately 4-fold increase was observed in patients with severe renal impairment, including patients with ESRD on hemodialysis, as compared to normal healthy control subjects
2x Better results* The EllieMD Program is a community-powered ecosystem integrating an expert doctor network, dedicated partner pharmacy, and prescription-grade personalization
Journal of applied physiology , 110 3, 774-80
Kiani F, et al
The H2O2 stimulon in Saccharomyces cerevisiae